Distinct roles of programmed death ligand 1 alternative splicing isoforms in colorectal cancer

Although anti–programmed death‐1 (PD‐1)/programmed death ligand 1 (PD‐L1) immunotherapy has achieved great success in some cancers, most colorectal cancer (CRC) patients remain unresponsive. Therefore, further clarification of the underlying mechanisms is needed to improve the therapy. In this study...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancer Sci
Asıl Yazarlar: Wang, Chaoyan, Weng, Menghan, Xia, Shuli, Zhang, Min, Chen, Chaoyi, Tang, Jinlong, Huang, Dan, Yu, Hongfei, Sun, Wenjie, Zhang, Honghe, Lai, Maode
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2020
Konular:
Cell, Molecular, and Stem Cell Biology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7780007/
https://ncbi.nlm.nih.gov/pubmed/33058325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14690
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller